Rituximab as Second-Line Treatment in Anti-NMDAR Encephalitis after Herpes Simplex Encephalitis in Children

Paula Carrascosa-García1, Lidia Oviedo-Melgares2, David Torres-Fernández3

  • 1Department of Pediatrics, Pediatric Infectious Diseases Unit, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), RITIP, Madrid, Spain.